Claret Asset Management’s Bio-Techne TECH Stock Holding History

Claret Asset Management’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$225K	Sell	3,182 -1,233	-28%	-$66.6K	0.02%	399
2026 Q1	$231K	Buy	4,415 +1	+0%	+$60	0.03%	283
2025 Q4	$260K	Sell	4,414 -10	-0.2%	-$608	0.03%	236
2025 Q3	$246K	Sell	4,424 -63	-1%	-$3.38K	0.03%	269
2025 Q2	$231K	Buy	+4,487	New	+$225K	0.03%	395
2024 Q4	–	Sell	-2,556	Closed	-$204K	–	348
2024 Q3	$204K	Buy	+2,556	New	+$192K	0.03%	311

Other funds holding TECH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Claret Asset Management's TECH Position: Q2 2026 in Review

Claret Asset Management reduced its Bio-Techne (TECH) stake by 28% in Q2 2026, selling an estimated $66.6K and leaving 3,182 shares worth $225K. The position accounts for 0.02% of the portfolio, ranked #399.

Claret Asset Management first reported a position in TECH in Q3 2024 and has held it in 6 quarters since. The position peaked at $260K in Q4 2025. 596 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

Claret Asset Management held 3,182 shares of Bio-Techne worth $225K as of Q2 2026.
Claret Asset Management sold 1,233 Bio-Techne shares in Q2 2026, an estimated $66.6K.
Bio-Techne made up 0.02% of Claret Asset Management's portfolio in Q2 2026, its #399 holding.
Claret Asset Management first reported a position in Bio-Techne in Q3 2024 and has held it in 6 quarters since.
Claret Asset Management's Bio-Techne position peaked at $260K in Q4 2025.
596 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Claret Asset Management's 13F filing for Q2 2026, filed 27 Jul 2026.